Ned named assistant dean of MD admissions
A longtime advocate for diversity and community outreach at Stanford has been appointed to help lead the medical admissions office.
Drug combo effective against dengue, Ebola
To develop a potential antiviral treatment, Stanford researchers adopted an unusual approach: Rather than trying to disable viral enzymes, they targeted proteins the infected individual makes — and the virus needs.
Experts: Funding ban harms women
“The reinstatement of the Mexico City policy is a stark example of ‘evidence-free’ policy making that ignores the best scientific data,” Nathan Lo and Michele Barry write.
Virtual reality helps surgery
Gina Milner’s successful surgery, the first at Packard Children’s to use the new imaging technology, is one of many examples of how virtual-reality techniques are now helping patients.
Volunteer devotes half a century to Stanford
When Martha Bachmann first volunteered as a “Pink Lady” in 1962, Stanford Hospital was known as Palo Alto-Stanford Hospital Center. Over her long career, she has watched the hospital expand dramatically.
Fighting for children’s health care
The health policy decisions made in Sacramento and Washington, D.C., impact health care programs, and these changes trickle down to communities where the results are deeply felt.
Magazine examines art’s role in medicine
When the arts and humanities play a role in medicine, patients, researchers and doctors can benefit. The winter issue of Stanford Medicine magazine features articles on the intersection of medicine with the arts and humanities.
Fast, brain-controlled typing achieved
In a Stanford-led research report, three participants with movement impairment controlled an onscreen cursor simply by imagining their own hand movements.
Listening to the brain
Stanford engineers and neurosurgeons have worked together to develop an experimental technology that could one day allow people with paralysis to affect the world around them using only their minds.
Pancreatic cells change fate to produce insulin
Alpha cells can convert to insulin-producing beta cells in mice when just two genes are blocked, a new Stanford study shows. A similar mechanism may occur in people with diabetes.